Party Members of the First Manufacturing Department of Pharmaceutical Industry Learn Party History
Release time:
2021-06-22
News from our newspaper 6# February 16 , the party branch of the first manufacturing department of Jianfeng Pharmaceutical Company held a party member conference to organize all party members to learn party history together. Zheng kunwu, secretary of the party branch of the first manufacturing department, took "
to comprehend the 100-year party history and strengthen road confidence" as the topic, focusing on the road of communism: the exploration from Marx to Lenin; The road of Chinese revolution: Mao Zedong led the people to stand up; The road of reform and opening up: Deng Xiaoping led the people to become rich; The road to national rejuvenation: xi Jinping led the people to strengthen and other aspects of the introduction and elaboration. He emphasized that the century-old history of the Communist Party of China is a history of unremitting struggle, ideological exploration, and self-construction. Looking back on a century of history and looking forward to a better tomorrow, the most important thing is to strengthen self-confidence in the road, theory, system and culture of socialism with Chinese characteristics. Qin Xuping, member of the Party Committee of the Group and Director of the Party and Mass Work Department, attended the meeting and introduced why to study party history, how to understand the party's century-old history, and what purpose to carry out party history education, etc., and strictly abide by politics Rules and political discipline, correctly understand the history of the party and the history of New China, with feelings, thoughts and methodology, the four aspects of persisting in striving for the vanguard, setting an example, and being a leader in studying and implementing party history put forward requirements for the development of party history study and education. He also asked party members to actively pay attention to the national situation and earnestly study "On the History of the Communist Party of China", "Questions and Answers on the Study of Xi Jinping's Thoughts on Socialism with Chinese Characteristics in the New Era", "Excerpts from Mao Zedong, Deng Xiaoping, Jiang Zemin, and Hu Jintao on the History of the Communist Party of China", "A Brief History of the Communist Party of China" four books must be read. At the
meeting, the participating party members also exchanged and shared how party members can take the lead. (Reporter
Ni Yingzhen) Party members ofPharmaceutical Company visited Suichang Red Revolution Base
News from our newspaper6
12 , the General Party Branch of Jinhua Pharmaceutical Company organized all Party members to visit Suichang Red Revolution Base - Wangcunkou Town. 1935 7# In late May, the Chinese Workers' and Peasants' Red Army marched into the division headquarters and entered Wangcunkou Town under the leadership of Su Yu and Liu Ying. A revolutionary base area was set up here. It led the marching division to carry out three years of arduous guerrilla warfare and carried out an agrarian revolutionary movement with the township and village red regimes to fight against local tyrants and divide young seedlings. Under the leadership of Wu Weisheng, secretary of the general party branch of the pharmaceutical company, all party members reviewed the oath of joining the party in the face of the party flag. Subsequently, under the leadership of the commentators of the red base, the party members visited the former site of the Red Army's marching division oath meeting, the office of the main leaders of the marching division, the Red Army stage, the Su Yu cemetery, the former site of the Soviet government, the former site of the Cai Xiangmiao, the former site of the Su Yu speech venue (Hongji Bridge), and the Chinese Workers' and Peasants' Red Army marching Division Memorial Hall. At every revolutionary site, party members listened carefully to the explanation with reverence and carefully visited every red cultural relic. An octagonal military hat, a pair of straw sandals, and a rusty broadsword pike are all silently telling the scene of how the Red Army fought to the end with these backward weapons against the powerful enemy. Pictures and graphic materials also tell the revolutionary story of that year.
During the one-day visit and study, the party members visited the revolutionary historical place and listened to the heroic deeds of the martyrs. Everyone expressed that they were deeply encouraged and educated, and they would cherish and protect today's hard-won happy life. (Fu Senqiang)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31